Angeion
This article was originally published in The Gray Sheet
Executive Summary
CE mark is received for the Model 2020 implantable cardiac defibrillator series, the firm announces June 16. Ela Medical is distributing the ICDs in Europe, where they will be sold under the trade name Lyra. Measuring 46 cc and weighing 87 grams, the 2020 is 25% smaller than the firm's 60 cc, 110 gram Sentinel ICD series. The Model 2020 family also includes the Model 2021 three-port header device and Model 2022, a replacement device which can be used with a variety of leads. U.S. clinical trials for the 2020 series at 35 centers are ongoing ("The Gray Sheet" Feb. 9, In Brief)
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.